Glenmark Pharmaceuticals Inc., USA recalls Rizatriptan Benzoate Tablets USP
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- CGMP Deviations: N-Nitroso Desmethyl Rizatriptan Impurity results that are above the FDA acceptable limit.
- Products
-
- Rizatriptan Benzoate Tablets USP
- Where it was sold
-
US Nationwide.
Nationwide
- Units affected
- 11,976 cartons
- About this recall
- Rizatriptan Benzoate Tablets USP, 10 mg, 18 (3 X 6) Unit-Dose Tablets, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430 Product of India, NDC 68462-466-99